Cancers are heterogeneous in biology among patients, tumors in the same patient, and within tumors. As a result, they respond differently to therapy per patient, per tumor and within tumors. Different radiotracers and imaging modalities provide information about different aspects of biology and the physio-metabolic environments of the cancer. As a result, a single modality or radiotracer may not provide sufficient information to predict or assess response to therapy. We hypothesize that improved prediction and assessment of response can thus be obtained by combining quantitative image-derived parameters obtained from multiple imaging modalities or radiotracers. We propose to develop, optimize, and validate approaches for combining multiple image-derived parameters obtained from quantitative imaging procedures in order to optimally predict and assess treatment response. In particular, we propose to combine quantitative metrics from PET/CT, SPECT/CT, and MRI. We will first individually optimize the protocols, acquisition parameters, and imaging methods in order to get the most accurate and reliable parameters to combine. Optimally combining the parameters from different modalities requires knowledge of the reproducibility (precision) of the individual quantitative imaging parameters. We will thus use literature search, phantom studies, realistic simulations, and repeated patient studies to characterize the accuracy and precision of the individual quantitative imaging methods. We will then develop methods to combine the metrics to predict or assess treatment response per patient, per tumor and intra-tumor. We will apply and evaluate these methods in three clinical trials: dynamic and static FDG and FIT PET/CT to assess lung cancer response to cytotoxic chemotherapy;PET/CT and DCE- and DW-MRI in breast cancer response;and SPECT/CT, PET/CT and DCE- and DW-MRI to predict response of brain tumors to anti-angiogenic therapy. In these trials imaging parameters and their signatures will be linked to histology or survival outcomes to provide validation of the combined imaging parameter metrics.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project--Cooperative Agreements (U01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRLB-Y (M1))
Program Officer
Nordstrom, Robert J
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Johns Hopkins University
Schools of Medicine
United States
Zip Code
Yankeelov, Thomas E; Mankoff, David A; Schwartz, Lawrence H et al. (2016) Quantitative Imaging in Cancer Clinical Trials. Clin Cancer Res 22:284-90
Jha, Abhinav K; Caffo, Brian; Frey, Eric C (2016) A no-gold-standard technique for objective assessment of quantitative nuclear-medicine imaging methods. Phys Med Biol 61:2780-800
Jha, Abhinav K; Rodríguez, Jeffrey J; Stopeck, Alison T (2016) A maximum-likelihood method to estimate a single ADC value of lesions using diffusion MRI. Magn Reson Med :
Koshkin, Vadim S; Bolejack, Vanessa; Schwartz, Lawrence H et al. (2016) Assessment of Imaging Modalities and Response Metrics in Ewing Sarcoma: Correlation With Survival. J Clin Oncol :
Malyarenko, Dariya I; Newitt, David; J Wilmes, Lisa et al. (2016) Demonstration of nonlinearity bias in the measurement of the apparent diffusion coefficient in multicenter trials. Magn Reson Med 75:1312-23
Taghipour, Mehdi; Wray, Rick; Sheikhbahaei, Sara et al. (2016) FDG Avidity and Tumor Burden: Survival Outcomes for Patients With Recurrent Breast Cancer. AJR Am J Roentgenol 206:846-55
Yue, Jianting; Mauxion, Thibault; Reyes, Diane K et al. (2016) Comparison of quantitative Y-90 SPECT and non-time-of-flight PET imaging in post-therapy radioembolization of liver cancer. Med Phys 43:5779
Wahl, Richard L (2016) Quo Vadis: PET and Single-Photon Molecular Breast Imaging. J Nucl Med 57 Suppl 1:3S-8S
O, Joo Hyun; Lodge, Martin A; Wahl, Richard L (2016) Practical PERCIST: A Simplified Guide to PET Response Criteria in Solid Tumors 1.0. Radiology 280:576-84
Connolly, Roisin M; Leal, Jeffrey P; Goetz, Matthew P et al. (2015) TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer. J Nucl Med 56:31-7

Showing the most recent 10 out of 43 publications